Thorium Norway AS has entered into a long-term off-take agreement with entX Limited (Australia) for the supply of Radium-228. The agreement covers an initial five-year period, followed by a rolling 12-month mutual termination clause. Radium-228 will serve as a critical precursor for the production of medical isotopes used in advanced cancer treatments.